Ashutosh Kumar

Ashutosh Kumar

Auto-generated profile, based on publicly available information

Ashutosh Kumar

Department of Paediatrics, Armed Forces Medical College, Pune, India

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in The Journal of Pediatrics
Verified
Journal Article
Closed access
AKAshutosh Kumar
Ashutosh Kumar
RGRahul Subhash Gosavi
Rahul Subhash Gosavi
VSVenkataseshan Sundaram
Venkataseshan Sundaram
TOTejo pratap Oleti
Tejo pratap Oleti
AKArun Krishnan
Arun Krishnan
SDSourabh Dutta
Sourabh Dutta

11 August 2017 in BMJ Paediatrics Open
Verified
Journal Article
Open access
PDF file
AKAshutosh Kumar
Ashutosh Kumar
VSVenkataseshan Sundaram
Venkataseshan Sundaram
RYRahul Yadav
Rahul Yadav
TOTejo pratap Oleti
Tejo pratap Oleti
SMSrinivas Murki
Srinivas Murki
SDSourabh Dutta
Sourabh Dutta
Introduction Haemodynamically significant patent ductus arteriosus (hsPDA) is a common cause of mortality and morbidity in preterm infants. Existing medical therapies with ibuprofen or indomethacin have multiple adverse effects. Hence, an alternative drug like paracetamol given through oral route with less side effects need to be tested in an appropriate study design with least risk of bias to arrive at a conclusion. Methods and analysis Multisite, randomised, active-controlled, non-inferiority design. The primary objective is to study the efficacy of oral paracetamol for closure of hsPDA in comparison to oral ibuprofen in preterm neonates of <32 weeks’ gestation. Randomisation web-based and allocation concealment would be done; the treating team, investigators, outcome assessors and laboratory personnel would be blinded from the intervention. Echocardiography images would be coded for independent review. Closure of PDA by the end of last dose of study drug or earlier would be the study endpoint. A sample size of 196 neonates would be enrolled with a non-inferiority margin of 15%. Both intention-to-treat and per-protocol analysis will be done to assess the effect of contamination and protocol violations in the primary outcome. Ethics and dissemination The trial would follow international code of ethics for clinical trial. The trial protocol was approved by the Institute Ethics Committee of all three centres. All serious adverse events would be reported in detail to the Institute Ethics Committee. A written informed consent would be obtained from one of the parents. No plan has been made for dissemination. Trial registration number CTRI/2014/08/004805.

26 November 2022 in Journal of Clinical and Experimental Hepatology
Verified
Journal Article
Closed access
PDF file
RARajendra Prasad Anne
Rajendra Prasad Anne
EREmine A. Rahiman
Emine A. Rahiman
SDSankalp Dudeja
Sankalp Dudeja
AKAshutosh Kumar
Ashutosh Kumar

7 May 2020 in Nutrition in Clinical Practice
Verified
Journal Article
Closed access
PDF file
VTVishal Vishnu Tewari
Vishal Vishnu Tewari
AKAshutosh Kumar
Ashutosh Kumar
ASAmit Singhal
Amit Singhal
APArya Prakash
Arya Prakash
NPNayana Pillai
Nayana Pillai
JVJaya Varghese
Jaya Varghese

14 June 2019 in Journal of Tropical Pediatrics
Verified
Journal Article
Closed access
VTVishal Vishnu Tewari
Vishal Vishnu Tewari
AKAshutosh Kumar
Ashutosh Kumar
ASAmit Singhal
Amit Singhal
NPNayana Pillai
Nayana Pillai
APArya Prakash
Arya Prakash
VKVenkatnarayan Kannan
Venkatnarayan Kannan
In neonates with Rh-hemolytic disease, light emitting diode (LED) phototherapy allows delivery of high spectral irradiance (SI). A linear correlation exists between SI and efficacy of phototherapy with no saturation point. There is scant data on evaluation and early phototherapy using LED units in Rh-hemolytic disease. This study aimed to describe the hemoglobin (Hb), hematocrit (Hct), total serum bilirubin (TSB), phototherapy parameters and short-term outcomes in neonates with Rh-hemolytic disease. Maternal parameters for Rh-isoimmunization were recorded and monitoring of fetal anemia by Doppler ultrasound was done. Early intensive phototherapy within 1 h of birth was initiated for cord blood Hb below 13.6 g/dl and/or TSB greater than 2.8 mg/dl. Fifty Rh positive neonates were enrolled of which 11/50 (22%) received intrauterine transfusions. The maximum TSB remained below 18 mg/dl in 42/50 (84%) of neonates. The mean SI on the trunk was 56.260 ± 8.768 µW/cm2/nm and duration of phototherapy was 7 ± 3.29 days (mean ± SD). There was a positive correlation between strength of indirect antiglobulin test and cord blood Hb: correlation coefficient (r) = 0.295; direct antiglobulin test and duration of phototherapy: r = 0.331. Early packed red blood cell (PRBC) transfusion was required in 8/50 (16%) neonates while 20/50 (40%) required late transfusions. With a mean SI of 56.260 ± 8.768 µW/cm2/nm on the trunk, TSB remained below 18 mg/dl in majority thereby avoiding exchange transfusion. Early or late PRBC transfusion requirement was 1 (1-2) (median ± interquartile range).

1 June 2021 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
AMAtul Mishra
Atul Mishra
AKAshutosh Kumar
Ashutosh Kumar
AMAnkit Mathur
Ankit Mathur
VKVivek Kumar
Vivek Kumar
ASAmit Sreen
Amit Sreen